BofA raised the firm’s price target on Arthur J. Gallagher to $255 from $233 and keeps an Underperform rating on the shares. In recent months, the insurance broker group has retraced due to potential interest rate cuts and hints of slowing organic growth, notes the analyst, who contends that “for the first time in the post-pandemic era, the group no longer seems notably expensive.” However, the firm still has concerns that further retrenchment is possible at some as organic growth retreats towards long-term averages and lower investment income weighs on margins, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AJG:
- Arthur J. Gallagher price target raised to $270 from $264 at Argus
- Arthur J. Gallagher & Co. Acquires Acumen Advisors, Inc.
- Arthur J. Gallagher acquires Acumen Advisors
- Arthur J. Gallagher & Co. Acquires Health Insurance Consultants Australia
- Arthur J. Gallagher acquires Health Insurance Consultants Australia